Abstract
Traumatic brain injury (TBI) is an important public health problem with an increasing incidence in the last years. Relatively few cases are fatal; most individuals will survive and, in the long-term, the sequalae of TBI will include neuroendocrine dysfunctions with a much higher frequency than previously suspected. Patients who develop hypopituitarism after TBI present manifestations due to the number of deficient hormones, severity of hormonal deficiency, and the duration of hypopituitarism without diagnosis and treatment. The clinical spectrum of hypopituitarism is very large and many signs and symptoms of TBI survivors such as fatigue, concentration difficulties, depressive symptoms are nonspecific and overlap with symptoms of post-traumatic stress disorder and variably severe hypopituitarism related to brain damage remaining undiagnosed. This can explain why the diagnosis of hypopituitarism is often missed or delayed after this condition with potentially serious and hazardous consequences for the affected patients. Moreover, clinical experience cumulatively suggests that TBI-associated hypopituitarism is associated with poor recovery and worse outcome, since post-traumatic hypopituitarism is independently associated with cognitive impairment, poor quality of life, abnormal body composition, and adverse metabolic profile. In the present review, the current data related to clinical consequences of pituitary dysfunction after TBI in adult patients and therapeutic approaches are reported.
Similar content being viewed by others
References
Tanriverdi F, Schneider HJ, Aimaretti G, Masel BE, Casanueva FF, Kelestimur F (2015) Pituitary dysfunction after traumatic brain injury: a clinical and pathophysiological approach. Endocr Rev 36(3):305–342
Nguyen R, Fiest KM, McChesney J, Kwon CS, Jette N, Frolkis AD, Atta C, Mah S, Dhaliwal H, Reid A, Pringsheim T, Dykeman J, Gallagher C (2016) The international incidence of traumatic brain injury: a systematic review and meta-analysis. Can J Neurol Sci 43(6):774–785
Schneider HJ, Kreitschmann-Andermahr I, Ghigo E, Stalla GK, Agha A (2007) Hypothalamopituitary dysfunction following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a systematic review. JAMA 298(12):1429–1438
Cryan E (1918) Pituitary demage due to skull base fracture. Dtsch Med Wochenschr 44:1261
Kelly DF, Gonzalo IT, Cohan P et al (2000) Hypopituitarism following traumatic brain injury and aneurys mal subarachnoid hemorrhage: a preliminary report. J Neurosurg 93(5):743–752
Lieberman SA, Oberoi AL, Gilkison CR, Masel BE, Urban RJ (2001) Prevalence of neuroendocrine dysfunction in patients recovering from traumatic brain injury. J Clin Endocrinol Metab 86(6):2752–2756
Bondanelli M, De ML, Ambrosio MR et al (2004) Occurrence of pituitary dysfunction following traumatic brain injury. J Neurotrauma 21(6):685–696
Aimaretti G, Ambrosi B, Di Somma C et al (2004) Traumatic brain injury and subarachnoid haemorrhage are conditions at high risk for hypopituitarism: screening study at 3 months after the brain injury. Clin Endocrinol 61(3):320–326
Aimaretti G, Ambrosio MR, Di SC et al (2005) Residual pituitary function after brain injury-induced hypopituitarism: a prospective 12-month study. J Clin Endocrinol Metab 90(11):6085–6092
Agha A, Rogers B, Sherlock M et al (2004) Anterior pituitary dysfunction in survivors of traumatic brain injury. J Clin Endocrinol Metab 89(10):4929–4936
Agha A, Thornton E, O’Kelly P et al (2004) Posterior pituitary dysfunction after traumatic brain injury. J Clin Endocrinol Metab 89(12):5987–5992
Popovic V, Pekic S, Pavlovic D et al (2004) Hypopituitarism as a consequence of traumatic brain injury (TBI) and its possible relation with cognitive disabilities and mental distress. J Endocrinol Invest 27(11):1048–1054
Leal-Cerro A, Flores JM, Rincon M et al (2005) Prevalence of hypopituitarism and growth hormone deficiency in adults long-term after severe traumatic brain injury. Clin Endocrinol (Oxf) 62(5):525–532
Agha A, Sherlock M, Phillips J et al (2005) The natural history of post-traumatic neurohypophysial dysfunction. Eur J Endocrinol 152(3):371–377
Agha A, Phillips J, O’Kelly P et al (2005) The natural history of post-traumatic hypopituitarism: implications for assessment and treatment. Am J Med 118(12):1416
Schneider HJ, Schneider M, Saller B et al (2006) Prevalence of anterior pituitary insufficiency 3 and 12 months after traumatic brain injury. Eur J Endocrinol 154(2):259–265
Tanriverdi F, Senyurek H, Unluhizarci K et al (2006) High risk of hypopituitarism after traumatic brain injury: a prospective investigation of anterior pituitary function in the acute phase and at 12-months after the trauma. J Clin Endocrinol Metab 91(6):2105–2111
Herrmann BL, Rehder J, Kahlke S et al (2006) Hypopituitarism following severe traumatic brain injury. Exp Clin Endocrinol Diabetes 114(6):316–321
Klose M, Juul A, Poulsgaard L et al (2007) Prevalence and predictive factors of post-traumatic hypopituitarism. Clin Endocrinol 67(2):193–201
Park KD, Kim DY, Lee JK, Nam HS, Park YG (2010) Anterior pituitary dysfunction in moderate-to-severe chronic traumatic brain injury patients and the influence on functional outcome. Brain Inj 24(11):1330–1335
Tanriverdi F, Taheri S, Ulutabanca H et al (2008) Apolipoprotein E3/E3 genotype decreases the risk of pituitary dysfunction after traumatic brain injury due to various causes: preliminary data. J Neurotrauma 25:1071–1077
Tanriverdi F, De Bellis A, Bizzarro A et al (2008) Antipituitary antibodies after traumatic brain injury: is head trauma-induced pituitary dysfunction associated with autoimmunity? Eur J Endocrinol 159:7–13
Karaca Z, Tanrıverdi F, Ünlühızarcı K, Kelestimur F (2016) GH and pituitary hormone alterations after traumatic brain injury. Prog Mol Biol Transl Sci 138:167–191
Karamouzis I, Pagano L, Prodam F, Mele C, Zavattaro M, Busti A, Marzullo P, Aimaretti G (2016) Clinical and diagnostic approach to patients with hypopituitarism due to traumatic brain injury (TBI), subarachnoid hemorrhage (SAH), and ischemic stroke (IS). Endocrine 52(3):441–450
Tanriverdi F, Agha A, Aimaretti G, Casanueva FF, Kelestimur F, Klose M, Masel BE, Pereira AM, Popovic V, Schneider HJ (2011) Manifesto for the current understanding and management of traumatic brain injury-induced hypopituitarism. J Endocrinol Invest 34(7):541–543
Hannon MJ, Sherlock M, Thompson CJ (2011) Pituitary dysfunction following traumatic brain injury or subarachnoid haemorrhage - in “endocrine management in the intensive care unit”. Best Pract Res Clin Endocrinol Metab 25(5):783–798
Klose M, Watt T, Brennum J, Feldt-Rasmussen U (2007) Posttraumatic hypopituitarism is associated with an unfavorable body composition and lipid profile, and decreased quality of life 12months after injury. J Clin Endocrinol Metab 92:3861–3868
Prodam F, Gasco V, Caputo M, Zavattaro M, Pagano L, Marzullo P, Belcastro S, Busti A, Perino C, Grottoli S, Ghigo E, Aimaretti G (2013) Metabolic alterations in patients who develop traumatic brain injury (TBI)-induced hypopituitarism. Growth Horm IGF Res 23(4):109–113
Molaie AM, Maguire J (2018) Neuroendocrine abnormalities following traumatic brain injury: an important contributor to neuropsychiatric sequelae. Front Endocrinol 9:176
Schneider HJ, Aimaretti G, Kreitschmann-Andermahr I, Stalla GK, Ghigo E (2007) Hypopituitarism Lancet 369(9571):1461–1470
Tan CL, Alavi SA, Baldeweg SE, Belli A, Carson A, Feeney C et al (2017) The screening and management of pituitary dysfunction following traumatic brain injury in adults: British neurotrauma group guidance. J Neurol Neurosurg Psychiatry 88(11):971–981
Quinn M, Agha A (2018) Post-traumatic hypopituitarism-who should be screened, when, and how? Front Endocrinol 9:8
Hannon MJ, Crowley RK, Behan LA, O’Sullivan EP, O’Brien MM, Sherlock M et al (2013) Acute glucocorticoid deficiency and diabetes insipidus are common after acute traumatic brain injury and predict mortality. J Clin Endocrinol Metab 98(8):3229–3237
Lanterna LA, Spreafico V, Gritti P, Prodam F, Signorelli A, Biroli F, Aimaretti G (2013) Hypocortisolism in noncomatose patients during the acute phase of subarachnoid hemorrhage. J Stroke Cerebrovasc Dis 22(7):e189–e196
Cohan P, Wang C, McArthur DL, Cook SW, Dusick JR, Armin B et al (2005) Acute secondary adrenal insufficiency after traumatic brain injury: a prospective study. Crit Care Med 33(10):2358–2366
Schneider HJ, Schneider M, Saller B, Petersenn S, Uhr M, Husemann B et al (2006) Prevalence of anterior pituitary insufficiency 3 and 12 months after traumatic brain injury. Eur J Endocrinol 154(2):259–265
Krewer C, Schneider M, Schneider HJ, Kreitschmann-Andermahr I, Buchfelder M, Faust M, Berg C, Wallaschofski H, Renner C, Uhl E, Koenig E, Jordan M, Stalla GK, Kopczak A (2016) Neuroendocrine disturbances one to five or more years after traumatic brain injury and aneurysmal subarachnoid hemorrhage: data from the German database on hypopituitarism. J Neurotrauma 33(16):1544–1553
Jonasdottir AD, Sigurjonsson P, Olafsson IH, Karason S, Sigthorsson G, Sigurjonsdottir HA (2018) Hypopituitarism 3 and 12 months after traumatic brain injury and subarachnoid haemorrhage. Brain Inj 32(3):310–317
Prodam F, Caputo M, Belcastro S, Garbaccio V, Zavattaro M, Samà MT, Bellone S, Pagano L, Bona G, Aimaretti G (2012) Quality of life, mood disturbances and psychological parameters in adult patients with GH deficiency. Panminerva Med 54(4):323–331
Undurti A, Colasurdo EA, Sikkema CL, Schultz JS, Peskind ER, Pagulayan KF, Wilkinson CW (2018) Chronic hypopituitarism associated with increased postconcussive symptoms is prevalent after blast-induced mild traumatic brain injury. Front Neurol 9:72
Tanriverdi F, Ulutabanca H, Unluhizarci K, Selcuklu A, Casanueva FF, Kelestimur F (2007) Pituitary functions in the acute phase of traumatic brain injury: are they related to severity of the injury or mortality? Brain Inj 21:433–439
Flesher MR, Delahanty DL, Raimonde AJ, Spoonster E (2001) Amnesia, neuroendocrine levels and PTSD in motor vehicle accident victims. Brain Inj 15:879–889
Wekking EM, Appelhof BC, Fliers E et al (2005) Cognitive functioning and well-being in euthyroid patients on thyroxine replacement therapy for primary hypothyroidism. Eur J Endocrinol 153:747–753
Denicoff KD, Joffe RT, Lakshmanan MC, Robbins J, Rubinow DR (1990) Neuropsychiatric manifestations of altered thyroid state. Am J Psychiatry 147:94 – 99
Desouza LA, Ladiwala U, Daniel SM, Agashe S, Vaidya RA, Vaidya VA (2005) Thyroid hormone regulates hippocampal neurogenesis in the adult rat brain. Mol Cell Neurosci 29:414–426
Cherrier MM, Craft S, Matsumoto AH (2003) Cognitive changes associated with supplementation of testosterone or dihydrotestosterone in mildly hypogonadal men: a preliminary report. J Androl 24:568–576
Cherrier MM, Matsumoto AM, Amory JK, Ahmed S, Bremner W, Peskind ER, Raskind MA, Johnson M, Craft S (2005) The role of aromatization in testosterone supplementation: effects on cognition in older men. Neurology 64:290 – 296
Jellinger KA, Paulus W, Wrocklage C, Litvan I (2001) Traumatic brain injury as a risk factor for Alzheimer disease. Comparison of two retrospective autopsy cohorts with evaluation of ApoE genotype. BMC Neurol 18:1–3
Genazzani AR, Pluchino N, Luisi S, Luisi M (2007) Estrogen, cognition and female ageing. Hum Reprod Update 13:175–187
Kampen DL, Sherwin BB (1994) Estrogen use and verbal memory in healthy postmenopausal women. Obstet Gynecol. 83, 979–983
Moffat SD (2005) Effects of testosterone on cognitive and brain aging in elderly men. Ann N Y Acad Sci 1055:80 – 92
Simpson H, Savine R, Sonksen P, Bengtsson BA, Carlsson L, Christiansen JS et al (2002) Growth hormone replacement therapy for adults: into the new millennium. Growth Horm IGF Res 12(1):1–33
McGauley GA, Cuneo RC, Salomon F, Sonksen PH (1990) Psychological well-being before and after growth hormone treatment in adults with growth hormone deficiency. Horm Res 33(4):52–54
Kelly DF, McArthur DL, Levin H, Swimmer S, Dusick JR, Cohan P et al (2006) Neurobehavioral and quality of life changes associated with growth hormone insufficiency after complicated mild, moderate, or severe traumatic brain injury. J Neurotrauma 23(6):928–942
Leon-Carrion J, Leal-Cerro A, Cabezas FM, Atutxa AM, Gomez SG, Cordero JM et al (2007) Cognitive deterioration due to GH deficiency in patients with traumatic brain injury: a preliminary report. Brain Inj 21(8):871–875
Tanriverdi F, Suer C, Yapislar H, Kocyigit I, Selcuklu A, Unluhizarci K, Casanueva FF, Kelestimur F (2013) Growth hormone deficiency due to sports-related head trauma is associated with impaired cognitive performance in amateur boxers and kickboxers as revealed by P300 auditory event- related potentials. Clin Endocrinol (Oxf) 78:730–737
Westwood AJ, Beiser A, Decarli C et al (2014) Insulin-like growth factor-1 and risk of Alzheimer dementia and brain atrophy. Neurology 82:1613–1619
Ozdemir D, Baykara B, Aksu I et al (2012) Relationship between circulating IGF-1 levels and traumatic brain injury-induced hippocampal damage and cognitive dysfunction in immature rats. Neurosci Lett 507:84–89
Luque RM, Lin Q, Cordoba-Chacon J, Subbaiah PV, Buch T, Waisman A, Vankelecom H, Kineman RD (2011) Metabolic impact of adult-onset, isolated, growth hormone deficiency (AOiGHD) due to destruction of pituitary somatotropes. PLoS ONE 6:e15767
Kelly DF, Chaloner C, Evans D, Mathews A, Cohan P, Wang C, Swerdloff R, Sim MS, Lee J, Wright MJ, Kernan C, Barkhoudarian G, Yuen KC, Guskiewicz K (2014) Prevalence of pituitary hormone dysfunction, metabolic syndrome, and impaired quality of life in retired professional football players: a prospective study. J Neurotrauma 31:1161–1171
Tanriverdi F, Kocyigit I, Unluhizarci K, Casanueva FF, Kelestimur F (2008) Body composition, serum IGF-I and leptin level changes in amateur boxers: retired boxers have risk factors for cardiovascular disorders. Obes Metab 4:118 – 123
Attanasio AF, Mo D, Erfurth EM, Tan M, Ho KY, Klein- berg D, Zimmermann AG, Chanson P, International Hy- popituitary Control Complications Study Advisory Board (2010) Prevalence of metabolic syndrome in adult hypopituitary growth hormone (GH)-deficient patients before and after GH replacement. J Clin Endocrinol Metab 95:74–81
Verhelst J, Mattsson AF, Luger A, Thunander M, Góth MI, Koltowska-Häggström M, Abs R (2011) Prevalence and characteristics of the metabolic syndrome in 2479 hypopituitary patients with adult-onset GH deficiency before GH re- placement: a KIMS analysis. Eur J Endocrinol 165:881–889
Giuliano S, Talarico S, Bruno L, Nicoletti FB, Ceccotti C, Belfiore A (2017) Growth hormone deficiency and hypopituitarism in adults after complicated mild traumatic brain injury. Endocrine 58(1):115–123
Jourdan C, Brugel D, Hubeaux K, Toure H, Laurent-Vannier A, Chevignard M (2012) Weight gain after childhood traumatic brain injury: a matter of concern. Dev Med Child Neurol 54(7):624–628
Verma A, Anand V, Verma NP (2007) Sleep disorders in chronic traumatic brain injury. J Clin Sleep Med 3(4):357–362
Crenn P, Hamchaoui S, Bourget-Massari A, Hanachi M, Melchior JC, Azouvi P (2014) Changes in weight after traumatic brain injury in adult patients: a longitudinal study. Clin Nutr 33(2):348–353
Glynn N, Agha A. Which patient requires neuroendocrine assessment following traumatic brain injury, when and how? Clin Endocrinol 78, 17–20 (2013)
Roberts I, Yates D, Sandercock P, Farrell B, Wasserberg J, Lomas G, Cottingham R, Svoboda P, Brayley N, Mazairac G, Laloë V, Muñoz-Sánchez A, Arango M, Hartzenberg B, Khamis H, Yutthakasemsunt S, Komolafe E, Olldashi F, Yadav Y, Murillo-Cabezas F, Shakur H, Edwards P (2004) CRASH trial collaborators. Effect of intravenous cortico- steroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): ran- domised placebo-controlled trial. Lancet 364:1321–1328
Fleseriu M, Hashim IA, Karavitaki N, Melmed S, Murad MH, Salvatori R, Samuels MH (2016) Hormonal replacement in hypopituitarism in adults: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 101(11):3888–3921
Cooper MS, Stewart PM (2007) Adrenal insufficiency in critical illness. J Intensive Care Med 22:348–362
Sundaram NK, Geer EB, Greenwald BD (2013) The impact of traumatic brain injury on pituitary function. Endocrinol Metab Clin North Am 42:565–583
Vanhorebeek I Van den (2004) BG. Hormonal and metabolic strategies to attenuate catabolism in critically ill patients. Curr Opin Pharmacol 4:621–628
Hatton J, Kryscio R, Ryan M, Ott L, Young B (2006) Systemic metabolic effects of combined insulin-like growth factor-I and growth hormone therapy in patients who have sustained acute traumatic brain injury. J Neurosurg 105:843–852
Takala J, Ruokonen E, Webster NR, Nielsen MS, Zandstra DF, Vundelinckx G, Hinds CJ (1999) Increased mortality asso- ciated with growth hormone treatment in critically ill adults. N Engl J Med 341:785–792
Aberg ND, Brywe KG, Isgaard J (2006) Aspects of growth hor- mone and insulin-like growth factor-I related to neuroprotection, regeneration, and functional plasticity in the adult brain. Sci World J 6:53–80
Arce VM, Devesa P, Devesa J (2013) Role of growth hormone (GH) in the treatment on neural diseases: from neuroprotection to neural repair. Neurosci Res 76:179 – 186
Devesa J, Reimunde P, Devesa P, Barbera M, Arce V (2013) Growth hormone (GH) and brain trauma. Horm Behav 63:331–344
Bhagia V, Gilkison C, Fitts RH et al (2010) Effect of recombinant growth hormone replacement in a growth hormone deficient subject recovering from mild traumatic brain injury: a case report. Brain Inj 24:560–567
Kreitschmann-Andermahr I, Poll EM, Reineke A et al (2008) Growth hormone deficient patients after traumatic brain injury—baseline characteristics and benefits after growth hormone replacement—an analysis of the German KIMS database. Growth Horm IGF Res 18:472–478
Gardner CJ, Mattsson AF, Daousi C, Karbonits M, Koltowska-Haggstrom M, Cuthbertson D (2015) Growth hormone deficiency after traumatic brain injury: improvement in quality of life with GH therapy-analysis of the KIMS database. Eur J Endocrinol 172:371–381
Moreau OK, Cortet-Rudelli C, Yollin E, Merlen E, Daveluy W, Rousseaux M (2013) Growth hormone replacement therapy in patients with traumatic brain injury. J Neurotrauma 30:998 – 1006
High WM Jr, Briones-Galang M, Clark JA, Gilkison C, Mossberg KA, Zgaljardic DJ, Masel BE, Urban RJ (2010) Effect of growth hormone replacement therapy on cognition after traumatic brain injury. J Neurotrauma 27:1565–1575
Reimunde P, Quintana A, Castanon B, Casteleiro N, Vilarnovo Z, Otero A, Devesa A, Otero-Cepeda XL, Devesa J (2011) Effects of growth hormone (GH) replacement and cognitive rehabilitation in patients with cognitive disorders after traumatic brain injury. Brain Inj 25:65–73
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Caputo M, Mele C, Prodam F, Marzullo P, Aimaretti G declare they have no conflict of interest.
Ethical approval
This article does not contain any studies with animals performed by any of the authors.
Research involving human and animal participants
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Caputo, M., Mele, C., Prodam, F. et al. Clinical picture and the treatment of TBI-induced hypopituitarism. Pituitary 22, 261–269 (2019). https://doi.org/10.1007/s11102-019-00956-w
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11102-019-00956-w